Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) stock price, news, charts, stock research, profile.
You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA) through any online brokerage.
Other companies in Kiniksa Pharmaceuticals’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Arcutis Biotherapeutics (NASDAQ:ARQT), Day One Biopharmaceutical (NASDAQ:DAWN), Xencor (NASDAQ:XNCR) and Mesoblast (NASDAQ:MESO).
Kiniksa Pharmaceuticals has a consensus price target of $35.57.
The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $20.5895 last updated December 20, 2024 at 4:00 PM EST.
There are no upcoming dividends for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
There is no upcoming split for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.